Clinical Studies
Clinical Studies
100% Clinically Proven. Peer Reviewed.
Restorsea is built on a scientific breakthrough: Aquabeautine XL®, a naturally occurring enzyme that only dissolves dead skin cells while leaving living cells completely intact. This is a biological function that has been clinically tested, peer-reviewed, and supported by 35 patents.
Our commitment to proof is why Restorsea has earned the trust of dermatologists, plastic surgeons, and medical professionals worldwide.
CLINICAL STUDIES
Peer Reviewed &
Published Clinical Studies
Every Restorsea product has undergone independent, dermatologist-supervised clinical testing, with results published in peer-reviewed medical journals.
STUDY #1
Journal of Drugs in Dermatology
An Evaluation of Efficacy and Tolerability of Novel Enzyme Exfoliation Versus Glycolic Acid in Photodamage Treatment.
Glycolic acid acts by chemical destruction of adhesions between skin cell to exfoliate superficial skin layers and excess pigmentation. It is well known to improve the appearance of photoaged skin, but is associated with varying degree of skin irritation. Hydrolyzed salmon roe proteins destroy cell adhesions enzymatically with potentially less irritation than acid treatments. This double-blind prospective study the efficacy and tolerability of hydrolyzed roe verus glycolic acid, and with crtric acid.
75 female subjects with mild to moderate photodamage, all skin types, and ages 31-70 years, were enrolled. In this 12 week study of twice daily self-treatments, patients were assigned to one of 3 groups;; Group 1 was assigned hydrolyzed roe cream, group 2, 4% glycolic acid, or group 3, 8% glycolic acid plus 2% citric acid. All patients used the same mild face wash and SPF 30 sunscreen throughout the study. Patients were evaluated at weed 0, 8, and 12 for objective and subjective tolerability, improvement in photodamage by VISIA Complexion Analysis, modified Packman and Gans method, Visual Analog Scale (VAS), and answered and opinion questionnaire.
Topical hydrolyzed roe protean used twice daily improves skin clarity. It has good tolerability with fewer instances of stinging and burning than other glycolic acid containing cream. Patient's opinions of the 3 products were similar.
STUDY #2
Journal of Clinical and Aesthetic Dermatology
Evaluation of the PRO Rebalancing Lotion in the reduction of facial erythema following a chemical peel treatment. Edema was also assessed.
Source: Journal of Clinical and Aesthetic Dermatology October 2016 JClin Aesthet Dermatol. 2016; 9(10):55-62.
Title: A Split-Face Evaluation to Assess the Efficacy of a Hydrolyzed Roe Cream in Reduction of Erythema Following Chemical Peel.
The PRO Rebalancing Lotion was applied to one side of the face of 30 healthy female subjects (average age=54.9 years, range 33-65 years) immediately following 4 to 15 minutes peel treatment. The opposite side remained untreated. Visia-CR digital photographs were taken at baseline and 8 and 24 hours post-facial peel. Objective dermal irritation assessments were done by a blinded investigator, graded on severity of facial erythema and edema on a 5-point scale; 0=none, 1=slight, 2=mild, 3=moderate, 4=severe. Subjects completed a perception questionnaire.
Reduction in erythema was greater (P less than or equal to: 0.05) for the treated side of the face compared to the untreated side at both 8 and 24 hours post-peel. Both sides showed reduction in erythema compared to immediate post-peel. No edema was observed. At eight hours, more than 50% of subjects agreed on the five attributes, and at 24 hours, 57% (17/30) of subjects agreed. At eight hours, greater than or equal to 80 percent of subjects strongly agreed or agreed that the treated skin feels hydrated and moisturized immediately after application. At 24 hours, more than 90 percent of subjects strongly agreed or agreed that treated skin feels perfectly hydrated and moisturized. When asked about their overall impression of the product, 60 percent (18 subjects) of subjects responded said, “I love it.” All subjects completed the study. No adverse events were reported.
PATENTS
Issued Patents
Restorsea holds 20 issued patents protecting every aspect of its Living Enzyme Technology, including:
- Proprietary methods for stabilizing a living enzyme in skincare formulas
- Manufacturing processes that preserve enzyme activity
- All non-pharmaceutical cosmetic applications of Aquabeautine XL®
This intellectual property portfolio extends protection through 2032, making Restorsea’s science truly one of a kind.
Restorsea Rejuvenating Day Cream
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913
*European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Revitalizing Eye Cream
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913
*European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Renormalizing Serum
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913
*European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Restoring Night Cream
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Rejuvenating Day Lotion SPF 30
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Retexturizing Body Butter
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Repairing Hand Treatment
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Repairing Neck & Décolletage Treatment
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Australia Patent No. 2013212251
Brazilian Patent No. 11 2014 017913
Canada Patent No. 2,829,932
China Patent No. 103687586
*European Patent No. 2691069
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Mexico Patent No. 356912
Restorsea Revitalizing Scalp Treatment
U.S. Patent No. 9,248,167
Australia Patent No. 2014361780
Israel Patent No. 246041
Japan Patent No. 6089152
Philippine Patent No. 1-2016-500930
Brazilian Patent No. 11 2014 017913
Mexico Patent No. 356912
Restorsea PRO Intensive Treatment 10X
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea PRO All Day Every Day 3X Lotion
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913
*European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea PRO Rebalancing Lotion
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea PRO Intensive Hand Treatment 10X
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea PRO Line Blur Eye Cream
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913
*European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea 24k Liquid Gold Face Oil
U.S. Patent No. 9,498,430
U.S. Patent No. 9,433,564
Brazilian Patent No. 11 2014 017913 **European Patent No. 3100717
Restorsea PRO Line Firming Eye Serum
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Lip Magic
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Recharging Finishing Mist
U.S. Patent No. 8,992,996
Singapore Patent No. 194972
Canada Patent No. 2,829,932
Australia Patent No. 2013212251
China Patent No. 103687586
Japan Patent No. 6002734
South Korea Patent No. 10-1643556
Germany Patent No. 602013012189.3
Brazilian Patent No. 11 2014 017913 *European Patent No. 2691069
**European Patent No. 3100717
Mexico Patent No. 356912
Restorsea Reviving Cleanser
Australia Patent No. 2013212251
*European Patent No. 2691069
**European Patent No. 3100717
Singapore Patent No. 194972
South Korea Patent No. 10-1643556
Mexico Patent No. 356912
Restorsea Foaming Facial Cleanser
Australia Patent No. 2013212251
*European Patent No. 2691069
**European Patent No. 3100717
Singapore Patent No. 194972
South Korea Patent No. 10-1643556
Mexico Patent No. 356912
OUR PROMISE
The Restorsea Promise
We're so confident in our science that we offer a 100% money-back guarantee. If you don't see visible improvement in your skin after consistent use, simply email us. We'll process your refund immediately—no hassle, no questions, no fine print.
Why? Because we've spent 15 years and tens of millions of dollars proving these products work. When you have 35 patents, published clinical studies, and dermatologists recommending your formulations, you don't need to hide behind return policies. You just need to let the science speak for itself.
Try Restorsea risk-free.





